EUVIMEDEUVIMED entdecken
Crossref

No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

Luke P Dawson iD, Muhammad Rashid iD, Diem T Dinh iD, Angela Brennan iD, Jason E Bloom iD, Sinjini Biswas, Jeffrey Lefkovits iD, James A Shaw, William Chan iD, David J Clark, Ernesto Oqueli iD, Chin Hiew und 8 weitere

Circulation: Cardiovascular Interventions · 2024-04 · 17 (4)

DOI: 10.1161/circinterventions.123.013738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2024-04. Verfasst von Luke P Dawson und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia (L.P.D., D.T.D., A.B., S.B., J.L., W.C., C.M.R.…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Suboptimal coronary reperfusion (no reflow) is common in acute coronary syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes. We aimed to develop and externally validate a clinical risk score for angiographic no reflow for use following angiography and before PCI. METHODS: We developed and externally validated a logistic regression model for prediction of no reflow among adult patients undergoing PCI for acute coronary syndrome using data from the Melbourne Interventional Group PCI registry (2005–2020; development cohort) and the British Cardiovascular Interventional Society PCI registry (2006–2020; external validation cohort). RESULTS: A total of 30 561 patients (mean age, 64.1 years; 24% women) were included in the Melbourne Interventional Group development cohort and 440 256 patients (mean age, 64.9 years; 27% women) in the British Cardiovascular Interventional Society external validation cohort. The primary outcome (no reflow) occurred in 4.1% (1249 patients) and 9.4% (41 222 patients) of the development and validation cohorts, respectively. From 33 candidate predictor variables, 6 final variables were selected by an adaptive least absolute shrinkage and selection operator regression model for inclusion (cardiogenic shock, ST-segment–elevation myocardial infarction with symptom onset >195 minutes pre-PCI, estimated stent length ≥20 mm, vessel diameter

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionAcute Coronary SyndromeMyocardial InfarctionST Elevation Myocardial InfarctionNo-Reflow PhenomenonAdultHumansFemaleMiddle AgedAgedMaleCoronary AngiographyTreatment OutcomeRisk Factors

Stichwörter der Autor:innen

acute coronary syndromepercutaneous coronary interventionrisk factorsrisk scorestents

Autor:innen und Institutionen

  • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia (L.P.D., D.T.D., A.B., S.B., J.L., W.C., C.M.R., A.E.A., D.S.).
  • Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia (L.P.D., J.E.B., J.A.S., A.J.T., D.M.K., D.S.).
  • The Baker Institute, Melbourne, Victoria, Australia (L.P.D., J.E.B., J.A.S., D.M.K., D.S.).
  • Keele Cardiovascular Research Group, Centre for Prognosis Research, Stroke on Trent, United Kingdom (M.R., A.E.A., M.A.M.).
  • Department of Cardiovascular Sciences, National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre, Glenfield Hospital, University of Leicester, United Kingdom (M.R., A.E.A.).
  • University Hospitals of Leicester National Health Service (NHS) Trust, United Kingdom (M.R., A.E.A.).

ORCID-Profile: Luke P Dawson, Muhammad Rashid, Diem T Dinh, Angela Brennan, Jason E Bloom, Jeffrey Lefkovits, William Chan, Ernesto Oqueli, Andrew J Taylor, Christopher M Reid, David M Kaye, Mamas A Mamas, Dion Stub

Zitieren

APA

Dawson, L. P., Rashid, M., Dinh, D. T., Brennan, A., Bloom, J. E., Biswas, S., Lefkovits, J., Shaw, J. A., Chan, W., Clark, D. J., Oqueli, E., Hiew, C., Freeman, M., Taylor, A. J., Reid, C. M., Ajani, A. E., Kaye, D. M., Mamas, M. A., Stub, D., & MIG and BCIS Investigators (2024). No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score. Circulation: Cardiovascular Interventions, 17(4). https://doi.org/10.1161/circinterventions.123.013738

Vancouver

Dawson LP, Rashid M, Dinh DT, Brennan A, Bloom JE, Biswas S, et al. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score. Circulation: Cardiovascular Interventions. 2024;17(4). doi:10.1161/circinterventions.123.013738

BibTeX
@article{Dawson2024,
  author = {Dawson, Luke P and Rashid, Muhammad and Dinh, Diem T and Brennan, Angela and Bloom, Jason E and Biswas, Sinjini and Lefkovits, Jeffrey and Shaw, James A and Chan, William and Clark, David J and Oqueli, Ernesto and Hiew, Chin and Freeman, Melanie and Taylor, Andrew J and Reid, Christopher M and Ajani, Andrew E and Kaye, David M and Mamas, Mamas A and Stub, Dion and MIG and BCIS Investigators, MIG and BCIS Investigators},
  title = {No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  volume = {17},
  number = {4},
  doi = {10.1161/circinterventions.123.013738}
}
Kostenlos starten →